Literature DB >> 7691598

Phosphatidylinositol 3'-kinase associates with p145c-kit as part of a cell type characteristic multimeric signalling complex.

M S Shearman1, R Herbst, J Schlessinger, A Ullrich.   

Abstract

p145c-kit is expressed in cell lineages of diverse origin and appears to regulate distinct cell type characteristic functions. Independent mutations at the murine Dominant White Spotting (W) locus result in the alteration of p145c-kit tyrosine kinase activity and signalling potential, which differentially affects melanocyte migration, germ cell regeneration and hematopoietic cell differentiation. Molecules that may be involved in mediation and definition of p145c-kit signalling pathways were investigated in cell lines of hematopoietic, melanogenic and central nervous system origin. High-affinity association of endogenous cellular proteins with activated p145c-kit was limited to a characteristic set of molecules that correlated with the presence of phosphatidylinositol (PtdIns) 3'-kinase activity. The observed association pattern of proteins was cell type characteristic, and all of the proteins were displaced from the receptor by competition with excess receptor binding subunit of PtdIns 3'-kinase. Our data indicate that PtdIns 3'-kinase associates with p145c-kit as part of a multimeric signalling complex, and suggest that the cell type characteristic composition of this complex influences the signalling potential of p145c-kit in the diverse cell types in which it is expressed and thereby defines its cell type-specific functions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691598      PMCID: PMC413665          DOI: 10.1002/j.1460-2075.1993.tb06060.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  76 in total

1.  SH2 domains of the p85 alpha subunit of phosphatidylinositol 3-kinase regulate binding to growth factor receptors.

Authors:  C J McGlade; C Ellis; M Reedijk; D Anderson; G Mbamalu; A D Reith; G Panayotou; P End; A Bernstein; A Kazlauskas
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

2.  Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors.

Authors:  Y Yarden; J A Escobedo; W J Kuang; T L Yang-Feng; T O Daniel; P M Tremble; E Y Chen; M E Ando; R N Harkins; U Francke
Journal:  Nature       Date:  1986 Sep 18-24       Impact factor: 49.962

3.  Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus.

Authors:  L Coussens; C Van Beveren; D Smith; E Chen; R L Mitchell; C M Isacke; I M Verma; A Ullrich
Journal:  Nature       Date:  1986 Mar 20-26       Impact factor: 49.962

4.  Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity.

Authors:  D R Kaplan; M Whitman; B Schaffhausen; D C Pallas; M White; L Cantley; T M Roberts
Journal:  Cell       Date:  1987-09-25       Impact factor: 41.582

5.  An 81 kd protein complexed with middle T antigen and pp60c-src: a possible phosphatidylinositol kinase.

Authors:  S A Courtneidge; A Heber
Journal:  Cell       Date:  1987-09-25       Impact factor: 41.582

6.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

7.  Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation.

Authors:  M Whitman; D R Kaplan; B Schaffhausen; L Cantley; T M Roberts
Journal:  Nature       Date:  1985 May 16-22       Impact factor: 49.962

8.  Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors.

Authors:  P Hu; B Margolis; E Y Skolnik; R Lammers; A Ullrich; J Schlessinger
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

9.  Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate.

Authors:  M Whitman; C P Downes; M Keeler; T Keller; L Cantley
Journal:  Nature       Date:  1988-04-14       Impact factor: 49.962

10.  Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.

Authors:  Y Yarden; W J Kuang; T Yang-Feng; L Coussens; S Munemitsu; T J Dull; E Chen; J Schlessinger; U Francke; A Ullrich
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

View more
  5 in total

1.  SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain.

Authors:  M Kozlowski; L Larose; F Lee; D M Le; R Rottapel; K A Siminovitch
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

2.  C-kit expression in germinoma: an immunohistochemistry-based study.

Authors:  Hideo Nakamura; Hideo Takeshima; Keishi Makino; Jun-Ichi Kuratsu
Journal:  J Neurooncol       Date:  2005-11       Impact factor: 4.130

3.  The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors.

Authors:  Johanna Andersson; Helene Sjögren; Jeanne M Meis-Kindblom; Göran Stenman; Pierre Aman; Lars-Gunnar Kindblom
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

4.  Signal transduction of c-Kit receptor tyrosine kinase in CHRF myeloid leukemia cells.

Authors:  Sebastian Scholl; Cornelia Kirsch; Frank D Böhmer; Reinhard Klinger
Journal:  J Cancer Res Clin Oncol       Date:  2004-08-31       Impact factor: 4.553

Review 5.  Cellular Energetics of Mast Cell Development and Activation.

Authors:  Ryan P Mendoza; Dylan H Fudge; Jared M Brown
Journal:  Cells       Date:  2021-03-02       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.